Home » Stocks » OTLK » Financials

Outlook Therapeutics, Inc. (OTLK)

Stock Price: $2.23 USD -0.07 (-3.04%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Numbers in millions USD. Fiscal year is October - September.
Year2020201920182017201620152014
Revenue-8.153.093.812.985.229.05
Revenue Growth-163.84%-18.99%27.92%-42.91%-42.33%-
Gross Profit-8.153.093.812.985.229.05
Selling, General & Admin9.979.3714.2315.8821.5612.917.32
Research & Development26.3423.8118.5023.8132.7638.8814.12
Other Operating Expenses0.5311.270.000.000.000.000.00
Operating Expenses36.8444.4532.7339.6954.3351.7821.44
Operating Income-36.84-36.30-29.64-35.88-51.35-46.56-12.39
Interest Expense / Income1.763.473.895.631.852.300.90
Other Expense / Income-0.09-1.830.20-3.160.00-1.280.00
Pretax Income-38.51-37.93-33.74-38.35-53.20-47.58-13.29
Income Tax-3.27-3.41-3.650.500.10-0.190.44
Net Income-35.24-34.52-30.09-38.85-53.30-47.39-13.73
Preferred Dividends13.631.5217.931.189.845.616.93
Net Income Common-48.87-36.04-48.02-40.03-63.14-53.00-20.66
Shares Outstanding (Basic)72.5618.194.933.002.151.221.06
Shares Outstanding (Diluted)72.5618.194.933.012.151.221.06
Shares Change298.84%268.84%64.25%39.56%76.48%14.62%-
EPS (Basic)-0.67-1.98-9.74-13.36-29.36-43.44-19.44
EPS (Diluted)-0.67-1.98-9.74-14.40-29.36-43.44-19.44
Free Cash Flow Per Share-0.44-1.80-7.26-5.26-21.65-29.76-8.83
Gross Margin-100%100%100%100%100%100%
Operating Margin--445.6%-960.1%-941.4%-1,723.3%-892.1%-136.9%
Profit Margin--442.4%-1555.2%-1050.1%-2119.1%-1015.4%-228.3%
FCF Margin--401.8%-1,160.2%-414.5%-1,563.3%-695.1%-103.7%
EBITDA-36.20-31.11-26.79-30.03-48.95-43.46-11.51
EBITDA Margin--381.9%-867.8%-787.9%-1642.9%-832.7%-127.2%
EBIT-36.75-34.47-29.85-32.72-51.35-45.29-12.39
EBIT Margin--423.1%-966.7%-858.5%-1,723.3%-867.7%-136.9%